Macrophage deactivation by interleukin 10 - PubMed (original) (raw)

Macrophage deactivation by interleukin 10

C Bogdan et al. J Exp Med. 1991.

Abstract

Recombinant mouse interleukin 10 (IL-10) was exceedingly potent at suppressing the ability of mouse peritoneal macrophages (m phi) to release tumor necrosis factor alpha (TNF-alpha). The IC50 of IL-10 for the suppression of TNF-alpha release induced by 0.5 microgram/ml lipopolysaccharide was 0.04 +/- 0.03 U/ml, with as little as 1 U/ml suppressing TNF-alpha production by a factor of 21.4 +/- 2.5. At 10 U/ml, IL-10 markedly suppressed m phi release of reactive oxygen intermediates (ROI) (IC50 3.7 +/- 1.8 U/ml), but only weakly inhibited m phi release of reactive nitrogen intermediates (RNI). Since TNF-alpha is a T cell growth and differentiation factor, whereas ROI and RNI are known to inhibit lymphocyte function, it is possible that m phi exposed to low concentrations of IL-10 suppress lymphocytes. m phi deactivated by higher concentrations of IL-10 might be permissive for the growth of microbial pathogens and tumor cells, as TNF-alpha, ROI, and RNI are major antimicrobial and tumoricidal products of m phi. IL-10's effects on m phi overlap with but are distinct from the effects of the two previously described cytokines that suppress the function of mouse m phi, transforming growth factor beta and macrophage deactivation factor. Based on results with neutralizing antibodies, all three m phi suppressor factors appear to act independently.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Immunol. 1987 Mar 15;138(6):1786-90 - PubMed
    1. J Exp Med. 1986 May 1;163(5):1037-50 - PubMed
    1. Eur J Immunol. 1988 Oct;18(10):1587-92 - PubMed
    1. J Exp Med. 1987 Aug 1;166(2):571-6 - PubMed
    1. Nature. 1988 Jul 21;334(6179):260-2 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources